Send mail to Author

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___      _____     _____     _____    __   __  
 /_   _//   / _ \\   / ____||  |  ___||  / ____||  \ \\/ // 
 `-| |,-   | / \ || / //---`'  | ||__   / //---`'   \ ` //  
   | ||    | \_/ || \ \\___    | ||__   \ \\___      | ||   
   |_||     \___//   \_____||  |_____||  \_____||    |_||   
   `-`'     `---`     `----`   `-----`    `----`     `-`'
 


Back to frontdoor view

OPUS4 Logo